Microarray analysis of mercury-induced changes in gene expression in human liver carcinoma (HepG2) cells: Importance in immune responses

International Journal of Environmental Research and Public Health

Volumn 3, Issue 2, 2006, Pages 141-173

  Ayensu, Wellington K ^a   Tchounwou, Paul B ^a  

^a Jackson State University   (United States)

Author keywords

Gene expression profile; Immune responses; Mercury; Oligonucleotide microarray

Indexed keywords

DNA; MERCURY;

AUTOIMMUNE DISEASE; CARCINOGENESIS; CELL CYCLE; CHROMOSOMAL LOCALIZATION; CONFERENCE PAPER; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HEPATOMA CELL; HUMAN; HUMAN CELL; HYBRIDIZATION; IMMUNE RESPONSE; LIVER CARCINOGENESIS; LIVER CARCINOMA; MERCURIALISM; MICROARRAY ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; ARTICLE; DNA MICROARRAY; DRUG EFFECT; GENE EXPRESSION PROFILING; LIVER; METABOLISM; POLLUTANT; TUMOR CELL LINE;

ANIMALIA;

CELL LINE, TUMOR; ENVIRONMENTAL POLLUTANTS; GENE EXPRESSION PROFILING; HUMANS; LIVER; MERCURY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 33846380022     PISSN: None     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph2006030018     Document Type: Conference Paper

References (72)

1. Pier, S. M.: The role of heavy metals in human health. Texas Rep Biol Med. 1975, 33(1), 85-106.
2. Whitekus, M. J.; Santini, R. P.; Rosenspire, A. J.; McCabe Jr., M. J.: Protection Against CD95-Mediated Apoptosis by Inorganic Mercury in Jurkat T Cells. The J. Immunol. 1999, 162, 7162-7170.
3. Ashkenazi, A.; Dixit, V. M.: Death receptors: signaling and modulation. Science 1998, 281:1305-1317.
4. Ashkenazi A.; Dixit V. M.: Death Receptors: Signaling and Modulation. Science 2002, 281(5381): 1305-1326.
5. Tartaglia, L. A.; Ayres, T. M.; Wong, G. H. W.; Goeddel, D. V.: A novel domain within the 55 kD TNF receptor signals cell death. Cell. 1993, 74, 45-53.
6. Nagata, S.; Goldstein, P.: The Fas death factor. Science 1995; 276: 1449-56.
7. Chinnaiyan, A. M.; O'Rourke, K.; Lane, B. R.; Dixit, V. M.: Interaction of CED-4 with CED-3 and CED-9, a molecular framework for cell death. Science. 1997, 275, 1122-6.
8. Akbar, A. N.; Salmon, M.; Savill, J.; Janossy, G.: A possible role for bcl-2 in regulating T cell memory-a 'balancing act' between cell death and survival. Immunol Today, 1993, 14, 526-31.
9. Dianzani, U.; Bragardo, M.; DiFranco, D.; Alliaudi, C.; Scagni, P.; Buonfiglio, D.; Redoglia, V.; Bonissoni, S.; Correra, A.; Dianzani, I.; Ramenghi, U.: Deficiency of the Fas Apoptosis Pathway Without Fas Gene Mutations in Pediatric Patients With Autoimmunity/Lymphoproliferation Blood, 1997, 89 (8), 2871-2879.
10. Maloy, K. J.; Powrie, F. Regulatory T cells in the control of immune pathology. Nat Immunol 2001, 2, 16-22.
11. Ansari, M. J. I.; Salama, A. D.; Chitnis, T.; Smith, R. N.; Yagita, H.; Akiba, H.; Yamazaki, T.; Azuma, M.; Iwai, H.; Khoury, S. J.; Auchincloss Jr., H.; Sayegh, M. H.: The programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice. J. Exp Med 2003, 198(1), 63-69.
12. Nishimura, H.; Okazaki, T.; Tanaka, Y.; Nakatani, K.; Hara, M.; Matsumori, A.; Sasayama, S.; Mizoguchi, A.; Hiai, H.; Minato, N.; Honjo, T.: Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 2001, 291, 319-322.
13. Mustelin, T.; Burn, P. Regulation of src family tyrosine kinases in lymphocytes. Trends in Biochemical Sciences 1993, 18, 215-220.
14. Mustelin, T.; Burn, P. Regulation of src family tyrosine kinases in lymphocytes. Trends in Biochemical Sciences 1993, 18, 215-220
15. Cifone, M. G.; De Maria, R.; Roncaioli, P.; Rippo, M. R.; Azuma, M.; Lanier, L. L.; Santoni, A.; Testi R. : Apoptotic signaling through CD95 (Fas/APO-1) activates an acidic sphingomyelinase. J Exp Med, 1993, 177, 1547-53.
16. Chan, H. M.: Metal accumulation and detoxification in humans. In Metal Metabolism in Aquatic Environments Langston W. J.; Bebianno M. J. eds), London: Chapman and Hall, 1998, 415-438.
17. Marsh, D. O.; Clarkson, T. W.; Myers, G. J.; Davidson, P. W.; Cox, C.; Cermichiari, E.; Tanner, M. A.; Lednar, W.; Shamlaye, C.; Choisy, O.:. The Seychelles study of fetal methylmercury exposure and child development: Introduction. Neurotoxicol 1995, 16:583-596.
18. Myers, G. J.; Davidson, P. W.; Cox, A.; Shamlaye, C. F.; Tanner, M. A.; Choisy, O.; Sloane-Reeves, J.; Marsh, D.; Cernichiari, E.; Choi, A.:. Neurodevelopmental outcomes of Seychellois children sixty-six months after in utero exposure to Methylmercury from a maternal fish diet: pilot study. Neurotoxicol, 1995, 16 (4): 639-652.
19. Tchounwou, P. B.; Ayensu, W. K; Ninashvili, N.; Sutton D.: Environmental Exposure to Mercury and its Toxico-Pathologic Implications to Public Health. Int. J. Environ. Res. Public Health, 2004, 1, 39-73.
20. ATSDR: Toxicological Profile for Mercury: TP-93/10. Agency for Toxic Substances and Disease Registry. Centers for Disease Control, Atlanta, Georgia. 1999.
21. Murphy, P. M.; Baggiolini, M.; Charo, I. F.; Hébert, C. A.; Horuk, R.; Matsushima K.; Miller, L. H.; Oppenheim, J. J.; Power, C. A.: International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors. Pharmacological Rev. 2000, 52 (1), 145-176.
22. Gupta, S. K.; Gallego, C.; Johnson, G. L.: Mitogenic pathways regulated by G proteins oncogenes. Molecular Biology and Cell, 1992, 3, 123-128.
23. Weiss, A.; Schlessinger, J.: Switching signals on or off by receptor dimerization. Cell, 1998, 94, 277-280.
24. Steinberg, A. D.; Raveché, E. S.; Laskin, C. A.; Smith, H. R.; Santoro, T.; Miller, M. L.; Plotz, P. H.: NIH conference. Systemic lupus erythematosus: insights from animal models. Ann Intern Med., 1984, 100, 714-727.
25. Drappa, J.; Kamen, L. A.; Chan, E.; Georgiev, M.; Ashany, D.; Marti, F.; King, P. D.: Impaired T cell death and lupus-like autoimmunity in T cell-specific adapter protein-deficient mice. J. Exp Med., 2003, 198(5), 809-821.
26. Bishop, J. M.: Molecular themes in oncogenes. Cell. 1991, 64, 235-248.
27. Hauptmann, R.; Swetly, P. A novel class of human type 1 interferons. Nuclei Acids Res., 1985, 13, 4739-4749.
28. Preble, O.T.; Rothko, K.; Klippel, J. H.; Friedman, R.M.; Johnston, M.I. Interferon-induced 2′-5′ adenylate synthetase in vitro by lymphocytes from systemic lupus erythematosus patients with and without circulating interferon. J. Exp. Med., 1983, 157, 2140-2146.
29. Adolf, G. R.: Monoclonal antibodies and enzyme immunoassays specific for human interferon IFNω1: evidence that IFN-ω is a component of human leukocyte IFN. Virology, 1990, 175, 410-417.
30. Cederblad, B.; Blomberg, S.; Vallin, H.; et al. Patients with systemic lupus erythematosus have reduced numbers for circulating natural interferon-alpha-producing cells. J. Autoimmunol., 1998, 11, 465-470.
31. Blomberg, S.; Eloranta, M.L.; Cederblad, B.; et al.: Presence of cutaneous interferon-α producing cells in patients with systemic lupus erythematosus. Lupus, 2001, 10484-490.
32. Hylton, W.; Cayley, J.; Dore, C.; Denman, A. M.: 2′ 5′Oligoadenylate synthetase induction in lymphocytes of patients with connective tissue diseases. Ann. Rheum. Dis., 1986, 45, 220-224.
33. Ronnblom, L. E.; Alm, G. V.; Oberg, K. E.: Autoimmunity after alpha-interferon therapy for malignant carcinoid tumor. Ann. Intern. Med., 1991, 115, 178-183.
34. Ytterberg, S. R.; Schnitzer, T. J.: Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum, 1982, 25, 401-406.
35. Ronnblom, L. E.; Alm, G. V.; Oberg, K. E.: Possible induction of systemic lupus erythematosus by interferon-α treatment in-patient with a malignant carcinoid tumor. J. Intern. Med. 1990, 227, 207-210.
36. Marrack, P.; Kappler, J.; Mitchell, T.: Type I interferon keep activated T cells alive. J. Exp. Med. 1999, 189, 521-529.
37. Su, L.; David, M.: Inhibition of B cell receptor-mediated apoptosis by IFN. J. Immunol., 1999, 162, 6317-6321.
38. Blanco, P.; Palucka, A. K.; Gill, M.; Pascual, V.; Banchereau, J.: Induction of dendritic cell differentiation by IFN-α in systemic lupus erythymatosus. Science, 2001, 294, 1540-1543.
39. Ronnblom, L.; Alm, G. V.: An etiopathogenic role for the type I IFN system in SLE. Trends Immunol., 2001, 22, 427-431.
40. Neubauer, R. H.; Goldstein, L.; Rabin, H.; Stebbing, N.: Stimulation of in vitro immunoglobulin production by interferon-α. J. Immunol., 1985, 134, 299-303.
41. Moore, P. A.; Belvedere, O.; Orr, A.; Bly, S. member of the tumor necrosis factor family and B lymphocyte stimulator. Science, 1999, 285, 260-263.
42. Hultman, P.; Lindh, U.; Horsted-Bindsev, P.: Activation of the immune system and systemic immune-complex deposits in Brown Norway rats with dental amalgam restorations. J. Dent. Res., 1998, 77, 1415-1425.
43. Hultman, P.; Bell, L. J.; Enestrom, S.; Pollard, K. M.: Murine susceptibility to mercury. I. Autoantibody profiles and systemic immune deposits in inbred, congenic and intra-H-2 recombinant strains. Clin. Immunol. Immuno-Pathol., 1992, 65: 98-108.
44. d congenic mice. Clin. Immunol. Immuno. Pathol., 1993, 68, 9-17.
45. H2 imbalance. J. Immunol., 1998, 161: 234-240.
46. 2-treated mice. Clin Immunol Immunopathol., 1997, 84, 328-333.
47. 2-induced autoimmunity in haplotype-heterozygous mice is an intrinsic property of B cells. J. Immunol., 2002, 161(4), 1778-1789.
48. 2 in Brown-Norway rats I. Production of monoclonal antibodies. J. Immunol. 1986, 36, 3272-3276.
49. Van der Pouw Kraan, T. C. T. M.; Van Gaalen, F. A.; Huizinga, T.W.; Pieterman, E.; Breedveld, F. C.; Verweij, C. L.: Discovery of distinctive gene expression profiles in rheumatoid synovium using cDNA microarray technology: evidence for the existence of multiple pathways of tissue destruction and repair. Genes and Immunity, 2003, 4, 187-196.
50. Fukui, Y.; Hashimoto, O.; Sanui, T.; Oono, T.; Koga, H.; Abe, M.; Inayoshi, A.; Noda, M.; Oike, M.; Shirai, T.; Sasazuki, T.: Haematopoietic cell specific CDM family protein DOCK2 is essential for lymphocyte migration. Nature, 2001, 412, 826-831.
51. Firestein, G. S.; Manning A. M.: Signal transduction and transcription factors in rheumatic disease. Arthritis Rheum, 1999, 42, 609-21.
52. Shi, X.; Xie, C.; Kreska, D.; Richardson, J. A.; Mohan, C.: Genetic Dissection of SLE. SLE1 and FAS Impact Alternate Pathways Leading to Lymphoproliferative Autoimmunity. J. Exp. Med., 2002, 196, 281- 292.
53. Manoury-Schwartz, B.; Chiocchia, G.; Bessis, N.; Abehsira-Amar, O.; Batteux, F.; Muller, S.; Huang, S.; Boissier, M. C.; Fournier, C.: High susceptibility to collagen-induced arthritis in mice lacking IFN- γ receptors. J. Immunol., 1997, 158, 5501-5506.
54. Vermeire, K.; Heremans, H.; Vandeputte, M.; Huang, S.; Billiau, A.; Matthys, P.: Accelerated collagen-induced arthritis in IFN-γ receptor-deficient mice. J. Immunol., 1997, 158, 5507-5513.
55. Shan, X. C.; Bourdeau, A.; Rhoton, A.: Characterization and mapping to human chromosome 8q24.3 of Ly-6-related gene 9804 encoding an apparent homologue of mouse TSA-1. J. Immunol., 1998, 160, 197-208.
56. Andre, I.; Gonzalez, A.; Wang, B.; Katz, J.; Benoist, C.; Mathis, D.: Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc Natl Acad Sci USA., 1996, 93, 2260-2274.
57. Hultgren, B.; Huang, X.; Dybdal, N.; Stewart, T. A.: Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice. Diabetes 1996, 45, 812-819.
58. Hall, A.: Ras-related proteins. Current Opinion in Cellular Biology, 1993, 5, 265-268.
59. Lowy, D. R.; Williamson, B. M.: Function and regulation of Ras. Annual Review of Biochemistry, 1993, 62, 851-891.
60. Ayensu, W. K.; Tchounwou, P. B.; McMurray, R. W.: Molecular and Cellular Mechanisms Associated with Autoimmune Diseases. Int. J. Environ. Res. Public Health, 2004, 1, 39-74.
61. Affymetrix manual: Affymetrix Technical Gene Chip manual version 5.0, 2002.
62. Tsao, B. P.; Cantor, R. M.; Kalunian, K. C.; et al. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J. Clin Invest 1997, 99, 725-731.
63. Drysdale, C. M.; McGraw D. W.; Stack, C. B.; et al.: Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci USA, 2000, 97, 10483-8.
64. Ruiz-Vera, A.; Gonzαlez De Buitrago, G.; Martinez-A, C.: Implication of calpain in caspase activation during B cell clonal deletion. EMBO J., 1999, 18, 4988-4998.
65. Wu, M.; Arsula, M.; Bellas, R. E.; FitzGerald, M. J.; Lee, H.; Schauer, S. L.; Sherr, D. H.; Sonensheink, G. E.: Inhibition of NF-κB/Rel induces apoptosis of murine B cells. Mol. Cell Biol. 1996, 16, 5015-5025.
66. Massagué, J.; Wotton, D.: Transcriptional control by the TGF-β/Smad signaling system. EMBO J. 2000, 19, 1745-1754.
67. ten Dijke, P.; Miyazono, K.; Heldin, C.-H.: Signalling input converge on nuclear effectors in TGF-β signaling. Trends Biochem. Sci., 2000, 25, 64-70.
68. Zhang, Y.; Derynck, R.: Regulation of Smad signalling by protein associations and signalling crosstalk. Trends Cell Biol, 1999, 9, 274-279.
69. Wakeland, E. K.; Liu, K.; Graham, R. R.; Behrens, T.W. Delineating the genetic basis of systemic lupus erythematosus. Immunity 2001, 15, 397-408.
70. Moser, L. M.; Neas, B. R.; Salmon, J. E.; Yu, H.; Gray-McGuire, C.; Asundi, N.; Fox, J.; Kelly, J.; Henshall, S.; Bacino, D.; Dietz, M.; Hogue, R.; Koelsch, G.; Nightingale, L.; Shaver, T.; Abdou, N. I.; Albert, D.A.; Carson, C.; Petr, M.; Treadwell, E.L.; James, J. A.; Harley, J. B.: Genome scan of human systemic lupus erythematosus: Evidence for linkage on chromosome 1q in African-American pedigrees. Proc. Nat. Acad. Sci. USA, 1998, 95, 14869-74.
71. Deapen, D. M.; Escalante, A.; Weinrib, L.; Horwitz, D. A.; Mack, M.: A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 1992, 35, 311-318.
72. Gaffney, P. M.; Ortmann, W. A.; Selby, S. A. et al.: Genome screening in human systemic lupus erythematosus: results from a second Minnesota cohort and combined analyses of sib-pair families. Am J Human Genet, 2000, 66, 547-556.